Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sexual fate of murine external genitalia development: Conserved transcriptional competency for male-biased genes in both sexes.
Kajioka D, Suzuki K, Matsushita S, Hino S, Sato T, Takada S, Isono K, Takeo T, Kajimoto M, Nakagata N, Nakao M, Suyama M, DeFalco T, Miyagawa S, Yamada G. Kajioka D, et al. Among authors: matsushita s. Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):e2024067118. doi: 10.1073/pnas.2024067118. Proc Natl Acad Sci U S A. 2021. PMID: 34074765 Free PMC article.
Sexually dimorphic expression of Mafb regulates masculinization of the embryonic urethral formation.
Suzuki K, Numata T, Suzuki H, Raga DD, Ipulan LA, Yokoyama C, Matsushita S, Hamada M, Nakagata N, Nishinakamura R, Kume S, Takahashi S, Yamada G. Suzuki K, et al. Among authors: matsushita s. Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16407-12. doi: 10.1073/pnas.1413273111. Epub 2014 Oct 31. Proc Natl Acad Sci U S A. 2014. PMID: 25362053 Free PMC article.
Single Nucleotide Polymorphisms of HAAO and IRX6 Genes as Risk Factors for Hypospadias.
Kojima Y, Koguchi T, Mizuno K, Sato Y, Hoshi S, Hata J, Nishio H, Hashimoto D, Matsushita S, Suzuki K, Miyagawa S, Hui CC, Tanikawa C, Murakami Y, Yamada G, Hayashi Y, Matsuda K. Kojima Y, et al. Among authors: matsushita s. J Urol. 2019 Feb;201(2):386-392. doi: 10.1016/j.juro.2018.07.050. J Urol. 2019. PMID: 30063927
Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial.
Fujimura T, Yoshino K, Kato H, Fukushima S, Ishizuki S, Otsuka A, Matsushita S, Amagai R, Muto Y, Yamazaki E, Kambayashi Y, Yahata T, Miyata T, Fujisawa Y, Asano Y. Fujimura T, et al. Among authors: matsushita s. Br J Dermatol. 2024 Jun 4:ljae231. doi: 10.1093/bjd/ljae231. Online ahead of print. Br J Dermatol. 2024. PMID: 38833158
1,267 results